Ranbaxy Q110 Sales In Africa Rose By 30%

To read the full article, please choose one of the following options:

BMI View: Pharmaceutical firms in the emerging markets are targeting other emerging markets for growth. As these drugmakers are generic, reaching countries that have low per-capita spending and high populations will form a key part of strategies for both geographic expansion and revenue growth. To this end, Indian drugmakers are increasing both manufacturing in and exports to Africa, which has a heavy disease burden and therefore sustainable high demand for medicines. As an example, Ranbaxy's recent investor presentation highlights Africa as one of it high growth regions for sales.